← Oncology Approval Tracker

FDA DECISION ·

Akeega

niraparib + abiraterone acetate · Janssen Biotech

FDA approvalNew or expanded indicationProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

With prednisone for adults with metastatic castration-sensitive prostate cancer and a deleterious or suspected deleterious BRCA2 mutation on an FDA-approved test.

LAMPGEN ANALYSIS

Why it matters

The label moves PARP inhibition into BRCA2-mutated disease before the castration-resistant stage.

What research teams should watch

Obtain the BRCA2 result early in metastatic care and plan hematologic, hepatic, blood pressure, and steroid adherence checks.

PRIMARY RECORDS

Sources